Apart from USFDA, the product is certified by MRI Global, ATCC (American Type Culture Collection), SGS (General Society of Surveillance-Geneva), FC, CE, ISO, UL, RoHS, UKRI Medical Research Council, CEN European Committee for Standardisation
Hong Kong-based Aurabeat has launched USFDA approved anti-COVID class 2 medical device for SARS-COV-2 disinfection in India.
Apart from USFDA, the product is certified by MRI Global, ATCC (American Type Culture Collection), SGS (General Society of Surveillance-Geneva), FC, CE, ISO, UL, RoHS, UKRI Medical Research Council, CEN European Committee for Standardisation.
Phil Yuen, CEO, Aurabeat, Hong Kong, said during the India launch, “We launched Aurabeat Anti-COVID disinfection technology in response to the global pandemic. We realized the urgent need for enclosed environments to be disinfected of the Covid-19 virus if mankind is to be kept safe. We have had demand surge for our anti-COVID disinfection products, and we are ramping up production to meet global demand.”
Venkat Duddukuri, CEO, Aurabeat India, added, “We are witnessing a resurgence of COVID cases across the globe, as also in India, and if any semblance of normalcy is to return, people’s freedom to return to their normal activities must be restored. Offices, schools, colleges, restaurants, theatres, can be cleansed of the Covid-19 virus with Aurabeat’s globally proven and approved technology.”
Aurabeat has developed the patented AG+ five-stage sterilisation purifying technology after extensive research in the field of air filtration for over a decade.
- Advertisement -